---
title: Clinical Case Conference (CPS)
subtitle: General Cardiology Lecture Series 
author: Anish S. Shah, MD, MS
institute: Division of Cardiology, Department of Medicine, University of Illinois Chicago 
date: April 8, 2024
format:
  revealjs:
    transition: fade
    transition-speed: fast
    slide-number: true
    incremental: true
    auto-animate-easing: ease-in-out
    auto-animate-unmatched: false
    progress: true
    chalkboard: true
---

# Introduction

## Objectives

1. Understand the __cognitive processes__ involved in the case-based diagnostic reasoning 
1. Identify __diagnostic assumptions__ that may lead towards case-specific biases
1. Practice __contextualizing clinical data__ in the framework of cardiovascular physiology


# History & Physical

---

30 year old gentleman with a history of acid reflux on PPI therapy, generalized anxiety disorder without long-term therapy, exercise-induced asthma on SABA inhaler therapy.

---

He had recurrent episodes of wheezing and cough over past 4-6 months, and was sent to the emergency room after being found to have a arterial saturation of 87% on room air.

. . .

Reports that he most prominently noted his dyspnea during sexual intercourse with his wife.

---

He improved with nebulizer therapy. 
Was seen by ENT at similar time, noting no upper respiratory causes for his symptoms.

. . .

Electrocardiography and chest roengenography was performed during his ER visit.

# Electrocardiography 

## {background-image="ecg-initial-pvc.png" background-size="contain"}

## {background-image="ecg-subsequent-pac.png" background-size="contain"}

# Chest Roentgenography

## {background-image="cxr-ap.gif" background-size="contain"}

## Reasoning {.smallest}

:::: {.columns}

::: {.column width="65%"}

::: {.fragment fragment-index=1}
Sinus tachycardia
:::

::: {.fragment fragment-index=2}
::: {.fragment .semi-fade-out fragment-index=6}
Right axis deviation with inferior [qR]{.red} and lateral [rS]{.red} pattern
:::
:::

::: {.fragment fragment-index=3}
::: {.fragment .semi-fade-out fragment-index=7}
[Complete interpolation]{.red} of ventricular ectopy with [superior axis]{.red} and inverted [transition at V2-V3]{.red}
:::
:::

::: {.fragment fragment-index=4}
::: {.fragment .semi-fade-out fragment-index=8}
Enlarged left-sided heart border with narrow vascular pedicle
:::
:::

::: {.fragment fragment-index=5}
::: {.fragment .semi-fade-out fragment-index=9}
[Earlier]{.red} completely interpolated atrial depolarization, as compared with PVC, at [similar cycle length]{.red}.
:::
:::

:::

::: {.column width="35%"}

::: {.fragment fragment-index=6}
::: {.fragment .highlight-current-red fragment-index=6}
Left posterior fascicular block
:::
:::

::: {.fragment fragment-index=7}
::: {.fragment .highlight-current-red fragment-index=7}
Inferior/posterior-septal PVC
:::
:::

::: {.fragment fragment-index=8}
::: {.fragment .highlight-current-red fragment-index=8}
Cardiomegaly
:::
:::

::: {.fragment fragment-index=9}
::: {.fragment .highlight-current-red fragment-index=9}
*Poor or abnormal VA conduction?*
:::
:::

:::

::::


---

Patient describes a 10+ year history of anabolic steroid usage, initiated by his coach as he trained as a body-builder. 

. . .

He continued as he was unsure on how to taper.

. . .

He had been on multiple testosterone and anabolic steroid supplements, and had most recently (past 3-6 months) trialed growth hormone.

. . .

Growth hormone was stopped due to lower extremity and hand swelling.

## Additional histories

. . .

Maternal grandfather died of sudden death at age 40, and mother has a potential "mitral valve prolapse". 
Father was a body-builder and had taken steroids previously.
No foreign travel, raised in Canada and lives in Chicago currently. 

. . .

No pets. Has a *1-year old son with his wife*, who are both healthy.

## Medications

- Chlorodehydromethyltestosterone (CDMT, a.k.a. *turinabol*) 
- Oxandrolone (active)
- Testosterone supplementation (active)
- Growth hormone injections (for 3-6 months prior to presentation)
- Albuterol inhaler PRN
- Omeprazole 40 mg PO daily

## Labs

:::: {.columns}

::: {.column width="50%"}

::: {.fragment fragment-index=1}
Sodium 138

Potassium 4.0 

Chloride 102 

CO2 24 

BUN 29

::: {.fragment .highlight-red fragment-index=3}
Creatinine 1.96 
:::

:::

:::

::: {.column width="50%"}

::: {.fragment fragment-index=2}
::: {.fragment .highlight-red fragment-index=3}
Hg 17.5 
:::

PLT 208

AST 35

::: {.fragment .highlight-red fragment-index=3}
ALT 52 
:::

Hemoglobin A1c 5.2%  

::: {.fragment .highlight-red fragment-index=3}
LDL 165, HDL 34 

Troponin I 105 (ng/L)

BNP 289
:::
:::

:::

::::

# Surface Echocardiography

## {background-image="tte-plax.gif" background-size="contain"}
## {background-image="tte-plax-zoom.gif" background-size="contain"}
## {background-image="tte-plax-zoom-color.gif" background-size="contain"}
## {background-image="tte-plax-lvidd.gif" background-size="contain"}
## {background-image="tte-psax-mid.gif" background-size="contain"}
## {background-image="tte-psax-mv.gif" background-size="contain"}
## {background-image="tte-psax-mv-color.gif" background-size="contain"}

## {background-image="tte-psax-high.gif" background-size="contain"}
## {background-image="tte-psax-high-rv-inflow-pw.gif" background-size="contain"}
## {background-image="tte-psax-high-rv-outflow-cw.gif" background-size="contain"}
## {background-image="tte-psax-high-rv-outflow-pw.gif" background-size="contain"}

## {background-image="tte-rv-inflow-color.gif" background-size="contain"}
## {background-image="tte-rv-inflow-cw.gif" background-size="contain"}
## {background-image="tte-rv-outflow.gif" background-size="contain"}
## {background-image="tte-rv-outflow-cw-vti.gif" background-size="contain"}
## {background-image="tte-rv-outflow-pw-vti.gif" background-size="contain"}

## {background-image="tte-a4c.gif" background-size="contain"}
## {background-image="tte-a4c-color-2.gif" background-size="contain"}
## {background-image="tte-a4c-color.gif" background-size="contain"}
## {background-image="tte-a4c-mv-color.gif" background-size="contain"}
## {background-image="tte-a4c-mitral-inflow-pw.gif" background-size="contain"}
## {background-image="tte-a4c-td-lateral.gif" background-size="contain"}
## {background-image="tte-a4c-td-septal.gif" background-size="contain"}
## {background-image="tte-a4c-m-mode-color.gif" background-size="contain"}
## {background-image="tte-a4c-zoom.gif" background-size="contain"}
## {background-image="tte-a4c-thrombus.gif" background-size="contain"}
## {background-image="tte-a2c.gif" background-size="contain"}
## {background-image="tte-a3c.gif" background-size="contain"}
## {background-image="tte-a5c-color.gif" background-size="contain"}
## {background-image="tte-a5c-cw.gif" background-size="contain"}
## {background-image="tte-a5c-pw.gif" background-size="contain"}
## {background-image="tte-a2c-definity.gif" background-size="contain"}

## Additional Labs

ACTH 20.4 
Free cortisol 1.0, AM cortisol 13
FSH < 0.2
LH < 0.2
Testosterone 1445 ng/dL
SPEP/UPEP negative
Lp(a) 21, ApoB100 126 (mg/dL)
Ferritin 194 
Iron 70 
TB negative
HIV negative
RVP negative
Hepatitis panel negative
ANA/Anti-SM negative
Trypanasoma cruzi IgG negative
Cystatin 0.9 (eGFR 81)

# Coronary Angiography

## {background-image="cath-lca-lao-cran.gif" background-size="contain"}

## {background-image="cath-lca-rao-caud.gif" background-size="contain"}

## {background-image="cath-rca-lao-ap.gif" background-size="contain"}

## {background-image="cath-rca-lao-caud.gif" background-size="contain"}

# Cardiac Magnetic Resonance Imaging

## {background-image="cmr-localizer.gif" background-size="contain"}

## {background-image="cmr-2c-cine.gif" background-size="contain"}

## {background-image="cmr-3c-cine.gif" background-size="contain"}

## {background-image="cmr-4c-cine.gif" background-size="contain"}

## {.center}

::: {layout-nrow=2}
![](cmr-sa-stack-2.gif)
![](cmr-sa-stack-3.gif)
![](cmr-sa-stack-4.gif)
![](cmr-sa-stack-5.gif)
![](cmr-sa-stack-6.gif)
![](cmr-sa-stack-7.gif)
:::

## {.center}

::: {layout-nrow=2}
![](cmr-sa-stack-8.gif)
![](cmr-sa-stack-9.gif)
![](cmr-sa-stack-10.gif)
![](cmr-sa-stack-11.gif)
![](cmr-sa-stack-12.gif)
![](cmr-sa-stack-13.gif)
:::

## {.center}

::: {layout-nrow=1}
![](cmr-av-pc-all.gif)
![](cmr-av-pc-high.gif)
![](cmr-av-pc-low.gif)
:::

## {.center}

::: {layout-nrow=1}
![](cmr-av-cine.gif){width=45%}
![](cmr-cor-lvot-cine.gif){width=45%}
:::

---

## {background-image="cmr-mag-ir-280-2c.gif" background-size="contain"}

## {background-image="cmr-mag-ir-280-3c.gif" background-size="contain"}

## {background-image="cmr-mag-ir-280-4c.gif" background-size="contain"}

## {background-image="cmr-mag-ir-280-sa.gif" background-size="contain"}

## {background-image="cmr-psir-fb-avg-sa.gif" background-size="contain"}

## {background-image="cmr-t1-scout.gif" background-size="contain"}

# Course

---

:::: {.columns}

::: {.column width="50%"}
Hospitalization: 

1. Patient was admitted to the cardiology service
1. Nephrology and endocrine consultation
1. Underwent coronary angiography and right heart catheterization
1. Underwent cardiac magnetic resonance imaging
1. Discharged with LifeVest
:::

::: {.column width="50%"}
Treatment: 

- atorvastatin 20
- apixiban 5 bid
- sacubitril-valsartan 24/26
- empagliflozin 10 
:::

::::


# References 

::: {#refs}

:::
